Cargando…
Quinolone-Based Third-Line Therapy for Helicobacter pylori Eradication
Currently, a standard third-line therapy for Helicobacter pylori (H. pylori) eradication remains to be established. Quinolones show good oral absorption, no major side effects, and marked activity against H. pylori. Several authors have studied quinolone-based third-line therapy and reported encoura...
Autores principales: | , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
the Society for Free Radical Research Japan
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2654467/ https://www.ncbi.nlm.nih.gov/pubmed/19308265 http://dx.doi.org/10.3164/jcbn.08-220R |